fda remove semaglutide from shortage list The Ozempic is over Novo Nordisk expands Wegovy access

The authors call for further research to evaluate clinical outcomes of HS patients treated with GLP-1 agonists, including effects on disease severity, weight management, and metabolic health

Innovent will make its breakthrough dual-target, liver fat-reducing weight loss therapy available to obese patients as soon as possible, to contribute towards the weight management and healthy China initiatives, said chairman Michael Yu Dechao, without giving a time frame.

Remien CH, Adler FR, Waddoups L, Box TD, Sussman NL

Conclusion Semaglutide is an effective option for managing type 2 diabetes and chronic weight issues, but its important for individuals to be mindful of potential side effects, including muscle loss

TB-500 is a synthetic fragment of thymosin beta-4 studied for tissue repair